Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Beginning Cash Balance: 2010-2024

Historic Beginning Cash Balance for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to $1.4 million.

  • China Pharma Holdings' Beginning Cash Balance fell 11.08% to $657,407 in Q3 2025 from the same period last year, while for Sep 2025 it was $751,066, marking a year-over-year decrease of 45.17%. This contributed to the annual value of $1.4 million for FY2024, which is 29.86% down from last year.
  • Per China Pharma Holdings' latest filing, its Beginning Cash Balance stood at $1.4 million for FY2024, which was down 29.86% from $2.0 million recorded in FY2023.
  • In the past 5 years, China Pharma Holdings' Beginning Cash Balance ranged from a high of $4.9 million in FY2022 and a low of $957,653 during FY2021.
  • Its 3-year average for Beginning Cash Balance is $2.8 million, with a median of $2.0 million in 2023.
  • As far as peak fluctuations go, China Pharma Holdings' Beginning Cash Balance skyrocketed by 407.39% in 2022, and later tumbled by 58.22% in 2023.
  • Yearly analysis of 5 years shows China Pharma Holdings' Beginning Cash Balance stood at $1.2 million in 2020, then dropped by 19.18% to $957,653 in 2021, then skyrocketed by 407.39% to $4.9 million in 2022, then slumped by 58.22% to $2.0 million in 2023, then dropped by 29.86% to $1.4 million in 2024.